Role of Malondialdehyde in the Age-Related Macular Degeneration

In my previous post I showed how SEQEX technology, “ICR,” is a unique PEMF therapy that cuts MDA levels by half!

Here, you’ll see that high MDA levels are associated with AMD (Age-Related Macular Degeneration).

So, reduce MDA and reverse AMD!  With non-invasive, safe, cell-recharging SEQEX technology.  In the USA it’s called the Health Harmonizer.

Abstract

The pathogenesis of age-related macular degeneration (AMD) is not clear. The most important risk factors for developing AMD are age, race, and smoking. Genetics, inflammation, and oxidative stress have all been suggested to play a role. The retina is rich in oxygen, free radicals, polyunsaturated fatty acid, and photoactive substances such as lipofuscin, and is exposed to high levels of visible irradiation. Aging is associated with increased oxidative injury. Lipid peroxidation and lipofuscin formation is also increased with aging. Malondialdehyde (MDA) is a product of lipid peroxidation and can be used as a biomarker for oxidative stress. In this chapter, we summarize the available evidence of oxidative stress in the pathogenesis of AMD. In addition, we have demonstrated that high levels of MDA were present in patients with AMD compared to patients without AMD. This suggests that lipid peroxidation-induced oxidative stress may play a role in the pathogenesis of AMD.

Source: Role of Malondialdehyde in the Age-Related Macular Degeneration

Share this Post!

About the Author : Dr. Jon Ritz

0 Comment

Leave a Comment